Naproxen Sodium Prices December 2023
Product
|
Category |
Region |
Price |
Naproxen Sodium |
Chemical |
USA |
41,587 USD/MT |
Naproxen Sodium |
Chemical |
China |
40,131 USD/MT |
Naproxen Sodium |
Chemical |
Germany |
40,775 USD/MT |
The price of naproxen sodium in the United States for Q4 2023 reached 41,587 USD/MT in December. The market in the United States saw a hike in product prices due to an increase in demand from the consumer sector and high costs of raw materials.
The price trend for naproxen sodium in China reached 40,131 USD/MT in December 2023. The market witnessed an upward trend as the pharmaceutical industries were forced to raise the medicines quotations due to high inflation. Furthermore, the consistent demand for the product gave manufacturers the opportunity to raise the prices.
In Germany, naproxen sodium prices touched 40,775 USD/MT in December 2023. The market saw a negative price trajectory due to a hike in interest rates that lowered the purchasing potential of the consumer sector.
Naproxen Sodium Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Naproxen Sodium Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of naproxen sodium pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of naproxen sodium at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of naproxen sodium price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing naproxen sodium price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
![Naproxen Sodium Price Trend](https://www.imarcgroup.com/CKEditor/c36a4297-69b7-443f-9cbf-09f4685b9d26pricing-reports.webp)
Naproxen Sodium Market Analysis
The global naproxen sodium market size reached 15,300 Tons in 2023. By 2032, IMARC Group expects the market to reach 24,145.3 Tons, at a projected CAGR of 5.20% during 2023-2032.
- The rising geriatric population has a profound impact on the expansion of the naproxen sodium market. According to recent findings, the proportion of the world’s population over 60 years will almost double from 12% to 22% between 2015 and 2050. Geriatric individuals are affected by pain-causing conditions like osteoporosis, arthritis, and other musculoskeletal disorders. These conditions require effective pain management solutions. Also, according to the World Health Organization (WHO), chronic diseases are on the rise, including those that cause severe pain. These diseases account for 41 million deaths, which is equivalent to 74% of all deaths worldwide.
- There is a rising incidence of chronic pain and inflammatory conditions, such as arthritis, back pain, and muscle pain, which is boosting this product’s popularity. During 2021, an estimated 20.9% of U.S. adults, which is about 51.6 million people, experienced chronic pain, and 6.9%, about 17.1 million persons, experienced high-impact chronic pain, which results in substantial restriction to daily activities. Also, according to the Centers for Disease Control and Prevention (CDC), the prevalence of chronic pain the U.S. adults ranged from 20.5% to 21.8% between 2019 and 2021. This alarming data has increased the use of naproxen sodium owing to its efficacy in giving long-lasting relief from pain and inflammation. Additionally, there has been a growing awareness and recognition of the importance of managing these conditions effectively, which is creating the demand for this drug.
- Heightened spending on healthcare is another robust driver of this market. There is a noticeable trend towards higher healthcare expenditure by governments and private entities, which helps in upgrading healthcare infrastructure and improving access to medications and healthcare services. In Europe, the general government spending on health amounted to €1221 billion or 7.7% of GDP in 2022. Similarly, in the U.S., healthcare spending saw a hike of 4.1%, reaching $4.5 trillion or $13493/person. As a result, more patients can obtain necessary treatments, including pain management therapies.
- The rising participation in sports and physical activities is leading to a higher number of injuries and musculoskeletal disorders. In 2022, a report by the Sports & Fitness Industry Association (SFIA), a US-based industry association, found that 237 million U.S. citizens took part in at least one sport, marking a 9.2% increase from 2017 and a 1.9% rise from 2021. Athletes and physically active individuals often experience conditions like sprains, strains, and tendinitis, which require effective pain management. Naproxen sodium is commonly used to alleviate pain and inflammation associated with sports injuries, making it a staple in sports medicine.
Naproxen Sodium News
The report covers the latest developments, updates, and trends impacting the global naproxen sodium market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in naproxen sodium production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the naproxen sodium price trend.
Latest developments in the naproxen sodium industry:
- In January 2023, Sun Pharma a major pharmaceutical company acquired three brands from Aksigen Hospital Care, including Disperzyme, Disperzyme-CD, and Phlogam (Trypsin BP 48 mg, Bromelain 90 mg, and Rutoside Trihydrate 100 mg). This acquisition will expand their anti-inflammatory medicine portfolio, including naproxen sodium.
- In May 2023, Camber Consumer Care added naproxen sodium tablets to its over-the-counter portfolio to give their customers an economical, high-quality, and well stocked option. Camber’s naproxen sodium tablets USP, 220 mg are available in 24, 50, 100, 200, 500 and 1,000 count bottles.
Product Description
Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that is used for pain relief and inflammation reduction. It is the sodium salt of naproxen, enhancing its solubility and absorption in the gastrointestinal tract. This drug is available in various forms, including tablets, capsules, and liquid suspensions. It exhibits unique properties, including potent anti-inflammatory, analgesic, and antipyretic effects. It finds application in the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, tendinitis, bursitis, acute gout, dysmenorrhea, mild to moderate pain, dental pain, and fever reduction.
Naproxen sodium offers numerous benefits, such as its effectiveness in reducing inflammation and pain, relatively long duration of action, availability in over-the-counter (OTC) and prescription forms, quick onset of action, well-documented safety profile, efficacy in chronic pain management, suitability for acute pain, reduction of fever, ease of administration, and its role in improving quality of life.
Regional Coverage
The report provides a detailed analysis of the naproxen sodium market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the naproxen sodium price trend.
Global Naproxen Sodium Price
The report offers a holistic view of the global naproxen sodium pricing trends in the form of naproxen sodium price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of naproxen sodium but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed naproxen sodium demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Naproxen Sodium Price
Europe saw a negative price trend in the last quarter of 2023. This is due to rising interest rates and the low purchasing power of consumers. Also, the ongoing interruptions in the development of innovative ways of producing pharmaceutical products caused by the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) over their view on the route of implementation had negatively influenced the price trend.
This analysis can be extended to include detailed naproxen sodium price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Naproxen Sodium Price
The market for naproxen sodium witnessed a positive price trend in the last quarter of 2023. This is due to rising costs of raw materials and high product demand from the consumer sector. Also, the Inflation Reduction Act of the US government, which aims to reduce the excessive cap on medical products such as naproxen sodium, was introduced to lower the rates, the prices did not drop as it will take time to yield results.
Specific naproxen sodium historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Naproxen Sodium Price
The report explores the naproxen sodium pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on naproxen sodium prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Naproxen Sodium Price
The naproxen sodium pricing trends in the Asia Pacific saw a positive movement owing to high inflation and rising quotation rates from the pharmaceutical sector. Also, there was a consistent product demand among consumers, which encouraged manufacturers to increase its prices.
This naproxen sodium price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Naproxen Sodium Price
The analysis of naproxen sodium prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Naproxen Sodium |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Naproxen Sodium Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of naproxen sodium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting naproxen sodium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The naproxen sodium price charts ensure our clients remain at the forefront of the industry.